Europe's Choice
Geopolitical shifts are reshaping life sciences. Europe can build on its strengths and lead or stand still and fall behind. What will it choose?
LEARN MOREHow can we ensure Europeans don't miss out on the latest advances in treatment?
EFPIA is asking EU leaders to work together with industry to create opportunities to, once again, make the region a world-leader in life sciences
EFPIA Code of Practice and relationships with patient organisations and healthcare professionals.
Latest Updates
VIEW ALL-
Blog articles 17.12.25
National Cancer Plans: Turning ambition into impact (Guest blog)
Plans are only as good as their tangible impact on patients and healthcare systems. Europe’s Beating Cancer Plan brought real momentum to the fight against...
Read Article -
Statements & press releases 16.12.25
EFPIA response to SANT Committee vote on the Critical Medicines Act: Important step although certain...
Europe needs a CMA that works rather than one that tries to address everything.
Read Article -
Statements & press releases 16.12.25
EFPIA and Vaccines Europe back the EU Safe Hearts Plan to improve cardiovascular health and call for...
With one in three deaths in the EU linked to cardiovascular disease and 13 million new diagnoses each year, swift implementation of the Plan is now essential. ...
Read Article -
External Event 13.01.26
What Happens if U.S. Pharmaceutical Prices Become the World’s Benchmark?
Join the CRA-moderated breakfast conversation during the J.P. Morgan Conference on the ripple effects, power shifts, and opportunities created if the world’s...
View Event -
Partner Event 19.01.26
Curious about Call 12? Join the IHI info webinars
The IHI Call Days for call 12 will take place online on 19 and 20 January 2026. These webinars will cover everything you need to know about the upcoming...
View Event -
External Event 24.03.26
DIA Europe 2026
Join the DIA Europe 2026 in March to explore how Europe can bring and keep innovation into the system to deliver better outcomes for patients.
View Event